SBH
AMPH icon

Segall Bryant & Hamill’s Amphastar Pharmaceuticals AMPH Stock Holding History

Segall Bryant & Hamill’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$672K Hold
33,318
– – 0.01% 561
2026
Q1 		$653K Buy
33,318
+22,133
+198% +$541K 0.01% 543
2025
Q4 		$300K Hold
11,185
– – ﹤0.01% 564
2025
Q3 		$298K Hold
11,185
– – ﹤0.01% 562
2025
Q2 		$257K Hold
11,185
– – ﹤0.01% 565
2025
Q1 		$324K Sell
11,185
-7,696
-41% -$246K 0.01% 565
2024
Q4 		$701K Sell
18,881
-87
-0.5% -$3.98K 0.01% 537
2024
Q3 		$921K Buy
+18,968
New +$832K 0.01% 516

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Segall Bryant & Hamill's AMPH Position: Q2 2026 in Review

Segall Bryant & Hamill held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 33,318 shares worth $672K. The position accounts for 0.01% of the portfolio, ranked #561.

Segall Bryant & Hamill first reported a position in AMPH in Q3 2024 and has held it in 8 quarters since. The position peaked at $921K in Q3 2024. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Segall Bryant & Hamill held 33,318 shares of Amphastar Pharmaceuticals worth $672K as of Q2 2026.
  • Segall Bryant & Hamill left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
  • Amphastar Pharmaceuticals made up 0.01% of Segall Bryant & Hamill's portfolio in Q2 2026, its #561 holding.
  • Segall Bryant & Hamill first reported a position in Amphastar Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Segall Bryant & Hamill's Amphastar Pharmaceuticals position peaked at $921K in Q3 2024.
  • 212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.